16
Participants
Start Date
February 28, 2006
Primary Completion Date
October 31, 2009
Study Completion Date
October 31, 2009
Intranodal injection of Ad-ISF35
Ad-ISF35, a replication-defective recombinant type V adenovirus encoding a recombinant humanized CD154 homolog (ISF35).
University of California, San Diego Moores Cancer Center, La Jolla
Collaborators (1)
Memgen, LLC
INDUSTRY
University of California, San Diego
OTHER